AAAAAA
Results:
1-15
|
Results: 15
Authors:
Ramratnam, B
Markowitz, MH
Citation: B. Ramratnam et Mh. Markowitz, Kinetics of human immunodeficiency virus type 1 replication and therapy, ANTIRETROVIRAL THERAPY, 2001, pp. 1-10
Authors:
Schols, D
De Clercq, E
Citation: D. Schols et E. De Clercq, Cellular receptors as targets for anti-human immunodeficiency virus agents, ANTIRETROVIRAL THERAPY, 2001, pp. 11-30
Authors:
Balzarini, J
De Clercq, E
Citation: J. Balzarini et E. De Clercq, Nucleoside and nucleotide reverse transcriptase inhibitors, ANTIRETROVIRAL THERAPY, 2001, pp. 31-62
Authors:
Balzarini, J
Esnouf, R
De Clercq, E
Citation: J. Balzarini et al., Nonnucleoside reverse transcriptase inhibitors, ANTIRETROVIRAL THERAPY, 2001, pp. 63-85
Authors:
Neamati, N
Marchand, C
Winslow, HE
Pommier, Y
Citation: N. Neamati et al., Human immunodeficiency virus type 1 integrase-targeted inhibitor design, ANTIRETROVIRAL THERAPY, 2001, pp. 87-104
Authors:
Karn, J
Citation: J. Karn, Inhibitors of transcription and transactivation as anti-human immunodeficiency virus agents, ANTIRETROVIRAL THERAPY, 2001, pp. 105-128
Authors:
Field, AK
Citation: Ak. Field, Oligonucleotides as antiretroviral agents, ANTIRETROVIRAL THERAPY, 2001, pp. 129-145
Authors:
Kempf, DJ
Molla, A
Hsu, A
Citation: Dj. Kempf et al., Protease inhibitors as anti-human immunodeficiency virus agents, ANTIRETROVIRAL THERAPY, 2001, pp. 147-174
Authors:
Tyms, AS
Citation: As. Tyms, Glycoprotein-processing enzymes as a target for human immunodeficiency virus chemotherapy, ANTIRETROVIRAL THERAPY, 2001, pp. 175-190
Authors:
Baba, M
Citation: M. Baba, Cellular factors as targets for anti-human immunodeficiency virus therapy, ANTIRETROVIRAL THERAPY, 2001, pp. 191-217
Authors:
Lambert, JS
Redfield, RR
Tramont, EC
Citation: Js. Lambert et al., Therapeutic human immunodeficiency virus vaccines: Concept, current status, and future directions, ANTIRETROVIRAL THERAPY, 2001, pp. 219-242
Authors:
Vandamme, AM
De Clereq, E
Citation: Am. Vandamme et E. De Clereq, Clinical usefulness of human immunodeficiency virus drug resistance monitoring, ANTIRETROVIRAL THERAPY, 2001, pp. 243-277
Authors:
Kavlick, MF
Mitsuya, H
Citation: Mf. Kavlick et H. Mitsuya, Emergence of drug-resistant human immunodeficiency virus type 1 (HIV-1) variants and their impact on antiretroviral therapy of HIV-1 infection, ANTIRETROVIRAL THERAPY, 2001, pp. 279-312
Authors:
Tremblay, C
Kaplan, JC
Hirsch, MS
Citation: C. Tremblay et al., Combination antiretroviral therapy, ANTIRETROVIRAL THERAPY, 2001, pp. 313-337
Authors:
Flexner, CW
Piscitelli, SC
Citation: Cw. Flexner et Sc. Piscitelli, Drug-drug interactions in human immunodeficiency virus infection, ANTIRETROVIRAL THERAPY, 2001, pp. 339-350
Risultati:
1-15
|